Rognoni, Carla
Milano, Carlo
Heffler, Enrico
Bonini, Matteo
Brussino, Luisa
Carpagnano, Giovanna Elisiana
Ricciardolo, Fabio Luigi Massimo
Costa, Francesco
Armeni, Patrizio
Article History
Received: 28 October 2022
Accepted: 27 April 2023
First Online: 2 June 2023
Declarations
:
: Not applicable.
: Not applicable.
: Fabio L.M. Ricciardolo reports grants, personal fees and other compensations from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK, Sanofi, Guidotti, Lusofarmaco, Mundipharma, Menarini and Novartis. In particular, Prof. Ricciardolo will receive a personal fee from Sanofi to participate in the work group for the current manuscript. The other authors have nothing to disclose.